Abstract：OBJECTIVE: To investigate the effect of pulmonary surfactant (PS) on the Th1/Th2 balance and serum levels of interleukin-4 (IL-4), interferon-γ (IFN-γ) and IgE in neonates with respiratory distress syndrome (RDS). METHODS: A total of 58 neonates with RDS were divided into control (n=20) and PS treatment groups (n=38). The control group underwent mechanical ventilation and other conventional treatment, while the PS treatment group received with bovine PS treatment within 1 hour of being admitted to the hospital together with mechanical ventilation and other conventional treatment. Enzyme-linked immunosorbent assay was used to measure serum levels of IL-4, IFN-γ and IgE before treatment and 24, 48 and 72 hours after treatment. Simultaneously, arterial blood gas, respiratory system compliance, and other ventilator parameters were recorded. RESULTS: Compared with the control group, the PS treatment group showed significantly shorter duration of mechanical ventilation and oxygen exposure time (P<0.05), significantly better respiratory system compliance and significantly lower oxygenation index 24, 48 and 72 hours after treatment (P<0.05). At 48 and 72 hours after treatment, serum levels of IFN-γ were significantly lower in the PS treatment group than in the control group (120±46 ng/L vs 229±59 ng/L, P<0.05; 141±40 ng/L vs 282±44 ng/L, P<0.05), and serum levels of IL-4 were significantly higher in the PS treatment group than in the control group (263±48 pg/mL vs 152±45 pg/mL, P<0.05; 417±49 pg/mL vs 201±46 pg/mL, P<0.05). At 72 hours after treatment, serum level of IgE was significantly lower in the PS treatment group than in the control group (115±44 pg/mL vs 199±43 ng/mL; P<0.05). CONCLUSIONS: PS treatment can shorten the duration of mechanical ventilation and oxygen exposure time, regulate serum levels of IFN-γ, IL-4 and IgE, and influence Th1/Th2 balance in neonates with RDS, thus inhibiting lung inflammatory response and reducing lung injury.
ZHAI Shu-Fen,LIU Cui-Qing,PING Li-Li et al. Effect of pulmonary surfactant on Th1/Th2 balance in neonates with respiratory distress syndrome[J]. CJCP, 2012, 14(12): 893-897.
［5］Kellner J, Gamarra F, Welsch U, Jorres RA, Huber RM, Bergner A. IL-13Rα2 reverses the effects of IL-13 and IL-4 on bronchial reactivity and acetylcholine-induced Ca2+ signalling［J］. Int Arch Allergy Immunol, 2007, 142(3): 199-210.
［8］Sweet DG, Carnielli V, Greisen G, Hallman M, Ozek E, Plavka R, et al. "European consensus guidelines on the management of neonatal respiratory distress syndrome in preterm infants-2010 update"［J］. Neonatology, 97(4): 402-417.
［10］Jobe AH, Ikegami M. Antenatal infection/inflammation and postnatal lung maturation and injury［J］. Respir Res, 2001, 2(1): 27-32.
［11］Speer CP. Chorioamnionitis, postnatal factors and proinflammatory response in the pathogenetic sequence of bronchopulmonary dysplasia ［J］. Neonatology, 2009, 95(4): 353-361.
［14］Mulligan MS, Warner RL, Foreback JL, Shanley TP, Ward PA. Protective effects of IL-4, IL-10, IL-12,and IL-13 in IgG immune complex-induced lung injury: role of endogenous IL-12［J］. J Immunol, 1997,159(7):3483-3489.
［15］Vecchiarelli A, Siracusa A, Monari C, Pietrella D, Retini C, Severini C. Cytokine regulation of low affinity IgE receptor (CD23) on monocytes from asthmatic subjects［J］. Clin Exp Immunol, 1994, 97(2):248-251.
［16］Berger A. Th1 and Th2 responses: What are they?［J］. BMJ, 2000, 321(7258): 424.
［17］Tanaka T, Hu-Li J, Seder RA, Fazekas de St Groth B, Paul WE. Interleukin 4 suppresses interleukin 2 and interferon gamma production by naive T cells stimulated by accessory cell-dependent receptor engagement［J］. Proc Natl Sci U S A, 1993, 90(13): 5914-5918.
［18］Koch L, Fritzsching B, Frommhold D, Poeschl J. Lipopolysaccharide-induced expression of Th1/Th2 cytokines in whole neonatal cord and adult blood: role of nuclear factorkappa B and p38 MAPK ［J］. Neonatology, 2011, 99(2): 140-145.
